Getting to the Heart of THI’s Work with TMCx
As a long-standing and active member institution of the Texas Medical Center, the Texas Heart Institute collaborates in a number...
Darren Woodside
Dr. James Martin – Director of the Cardiomyocyte Renewal Lab at Texas Heart Institute – Elected to the 2021 Class of the National Academy of Inventors
Houston, TX (February 11, 2021) – The Texas Heart Institute is pleased to announce that Dr. James Martin, Director of its...
Cell adhesion research could lead to a new pain alternative for patients with inflammatory conditions
Today more than 30 million patients suffer from painful inflammatory conditions. Prescription opioid pain relievers are commonly prescribed for these...
THI discovery targets inflammatory disease for patients suffering from IBD
Grant from the NIH NIDDK to Advance Collaboration to Develop Treatments for Inflammatory Disease HOUSTON, TX, November 10, 2020 –...
Discovery in the molecular cardiology research labs could improve immuno-oncology drugs, covid, and influenza vaccines
Texas Heart Institute scientists illuminated a molecular pathway that could one day strengthen the immune response to immunotherapies. The first-in-human...
Biomedical Engineer to Expand THI’s Innovation Partnerships
HOUSTON, TX (October 9, 2020) – The Texas Heart Institute is proud to announce the appointment of Dr. Allison Post...
Technology Co-Invented by THI Scientists In the News
Technology co-invented by scientists at the Texas Heart Institute and 7 Hills Pharma received broad patent protection from the U.S....
Texas Heart Institute & 7 Hills Pharma awarded a $1.9 million grant from National Heart Lung Blood Institute to improve stem cell transplantation
HOUSTON, TX (June 11, 2020) —The Texas Heart Institute and 7 Hills Pharma (7 Hills) received a $1.9 million, Phase...
Harnessing hydrogels to fine-tune the body’s inflammatory response
Rice University partnered with the Texas Heart Institute (THI) to define the body’s response to their injectable hydrogels that are...
